| [1] |
Du T, Zhu YJ. The regulation of inflammatory mediators in acute kidney injury via exogenous mesenchymal stem cells [J]. Mediators Inflamm, 2014, 2014：261697.
|
| [2] |
Chawl ALS, Bellomo R, Bihorac A, et al. Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup [J]. Nat Rev Nephrol, 2017, 13(4): 241-257.
|
| [3] |
Lu J, Yi Y, Pan R, et al. Berberine protects HK－2 cells from hypoxia/reoxygenation induced apoptosis via inhibiting SPHK1 expression [J]. J Nat Med, 2018, 72(2): 390-398.
|
| [4] |
Aitken A. Post－translational modification of 14－3－3 isoforms and regulation of cellular function [J]. Semin Cell Dev Biol, 2011, 22(7): 673-680.
|
| [5] |
Wang J, Jia H, Zhang B, et al. HucMSC exosome－transported 14－3－3zeta prevents the injury of cisplatin to HK－2 cells by inducing autophagy in vitro [J]. Cytotherapy, 2018, 20(1): 29-44.
|
| [6] |
Medina A, Ghahary A. Transdifferentiated circulating monocytes release exosomes containing 14－3－3 proteins with matrix metalloproteinase－1 stimulating effect for dermal fibroblasts [J]. Wound Repair Regen, 2010, 18(2): 245-253.
|
| [7] |
Hou Z, Peng H, White DE, et al. 14－3－3 binding sites in the snail protein are essential for snail－mediated transcriptional repression and epithelial－mesenchymal differentiation [J]. Cancer Res, 2010, 70(11): 4385-4393.
|
| [8] |
Pozuelo－Rubio M. Regulation of autophagic activity by 14－3－3zeta proteins associated with class III phosphatidylinositol－3－kinase [J]. Cell Death Differ, 2011, 18(3): 479-492.
|
| [9] |
Pozuelo－Rubio M. 14－3－3 Proteins are Regulators of Autophagy [J]. Cells, 2012, 1(4): 754-773.
|
| [10] |
Ghosh SK, Ganta A, Spanjaard RA. Discovery and cellular stress pathway analysis of 1，4－naphthoquinone derivatives with novel, highly potent broad－spectrum anticancer activity [J]. J Biomed Sci, 2018, 25(1): 12.
|
| [11] |
孙林，刘伏友，陈香美. 加强对急性肾脏病的认识与管理 [J/CD]. 中华肾病研究电子杂志，2017, 6(6): 241-245.
|
| [12] |
Burne－Taney MJ, Kofler J, Yokota N, et al. Acute renal failure after whole body ischemia is characterized by inflammation and T cell－mediated injury [J]. Am J Physiol Renal Physiol, 2003, 285(1): F87-94.
|
| [13] |
Si Y, Bao H, Han L, et al. Dexmedetomidine attenuation of renal ischaemia－reperfusion injury requires sirtuin 3 activation [J]. Br J Anaesth, 2018, 121(6): 1260-1271.
|
| [14] |
Xie Y, Xiao J, Fu C, et al. Ischemic Preconditioning Promotes Autophagy and Alleviates Renal Ischemia/Reperfusion Injury [J]. BioMed Research International, 2018, 2018：1-11.
|
| [15] |
Ryan MJ, Johnson G, Kirk J, et al. HK－2: an immortalized proximal tubule epithelial cell line from normal adult human kidney [J]. Kidney Int, 1994, 45(1): 48-57.
|
| [16] |
Gardino A K, Yaffe MB. 14－3－3 proteins as signaling integration points for cell cycle control and apoptosis [J]. Semin Cell Dev Biol, 2011, 22(7): 688-695.
|
| [17] |
Zhang B, Shi Y, Gong A, et al. HucMSC Exosome－Delivered 14－3－3zeta Orchestrates Self－Control of the Wnt Response via Modulation of YAP During Cutaneous Regeneration [J]. Stem Cells, 2016, 34(10): 2485-2500.
|
| [18] |
Chen CH, Chuang SM, Yang MF, et al. A novel function of YWHAZ/beta－catenin axis in promoting epithelial－mesenchymal transition and lung cancer metastasis [J]. Mol Cancer Res, 2012, 10(10): 1319-1331.
|
| [19] |
Chen S, Fu H, Wu S, et al. Tenascin－C protects against acute kidney injury by recruiting Wnt ligands [J]. Kidney Int, 2019, 95(1): 62-74.
|
| [20] |
Gao L, Zhong X, Jin J, et al. Potential targeted therapy and diagnosis based on novel insight into growth factors, receptors, and downstream effectors in acute kidney injury and acute kidney injury－chronic kidney disease progression [J]. Signal Transduct Target Ther, 2020, 5：9.
|
| [21] |
Xu J, Li PX, Wu J, et al. Involvement of the Hippo pathway in regeneration and fibrogenesis after ischaemic acute kidney injury: YAP is the key effector [J]. Clin Sci (Lond), 2016, 130(5): 349-363.
|